Based on the positive albeit low correlation between specific IgE and allergy symptoms before intervention, the close to 40% reduction in specific IgE levels in the AndosanTM group during pollen season is assumingly associated with the clinical findings. This evidence concerns the gene IGHE and allergic disease.